NCT06447675View on ClinicalTrials.gov

Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in Children With CDKL5 Deficiency

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

June 25, 2025

Study Completion Date

September 30, 2025

Conditions
CDKL5 Deficiency Disorder
Interventions
OTHER

Hyperthermic Baths

The intervention will consist of 12 weeks of repeated (2x/day) 20-min body immersions.

Trial Locations (1)

100053

Xuanwu Hospital,Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06447675 - Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in Children With CDKL5 Deficiency | Biotech Hunter | Biotech Hunter